Symbol Lookup

Wednesday May 25, 2016 2:43 PM ET. Data delayed 15 minutes.
-0.01 (-1.27%)
Open/Prev Close
Day Range
52-Week Range
Vol/Avg Daily Vol
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
BRIEF-Escalon Medical qtrly net loss $0.01
8:55PM ET on Monday May 16, 2016 by Thomson Reuters

May 16 (Reuters) - Escalon Medical Corp

* Qtrly net loss $0.01

* Qtrly revenues $ 3.1 million versus $3.4 million

* Escalon Medical Corp. reports third ...

Escalon(R) Medical Corp. Reports Third Quarter Fiscal 2016 Results
8:00PM ET on Monday May 16, 2016 by PR Newswire

Escalon Medical Corp. (NASDAQ: ESMC) today announced financial results for its third quarter of fiscal 2016, ended March 31, 2016.

For the third quarter of fiscal 2016, consolidated product revenue decreased $331,000 to $3,097,000 from $...

Company Information

Escalon Medical Corp. (Escalon) operates in the healthcare market, engaged in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. The Company operates in two segments: Sonomed-Escalon and Escalon Medical Corp. (Corporate). The Sonomed-Escalon segment includes Sonomed, Inc., Escalon Digital Solutions, Inc. (EMI) and Trek, Inc. (Trek), which are engaged in the development and sale of ophthalmic medical devices. The Escalon Medical Corp. segment includes the administrative corporate operations. The Company distributes two intraocular gas products C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery. The development of ultrasound ophthalmic equipment is performed at the Company's Lake Success, New York and Stoneham, Massachusetts facilities. The Company leases approximately 11,250 square feet of space in Wisconsin, for its surgical products.


HeadquartersSuite 200, 100 Church Street
ARDMORE, PA, United States 19003


Chairman of the BoardRichard DePiano
President, Chief Executive Officer, General Counsel, DirectorRichard DePiano
Chief Financial OfficerRobert O'Connor
Chief Operating OfficerMark Wallace
DirectorC. Todd Trusk

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$6.0MBeta-0.32
Revenue (TTM)$12.6MEPS$-0.15
Shares Out.7.5MBook Value$0.40
Dividend Yield0.00%P/E--
Annual Dividend Rate0.00 USDPrice/Sales (TTM)0.5
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin-8.69%

*GAAP = prior to non-GAAP analyst adjusted earnings.


Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample